耐碳青霉烯类肠杆菌目细菌定植情况与临床感染特征及危险因素分析

Analysis of colonization status, clinical infection characteristics, and risk factors for carbapenem-resistant Enterobacterales

  • 摘要:
    目的 分析耐碳青霉烯类肠杆菌目细菌(CRE)定植情况和临床感染特征, 并筛选其危险因素。
    方法 将2021年1月—2023年1月医院收治的129例CRE定植的患者纳入定植组,统计CRE菌种鉴定结果与科室分布情况。根据药敏试验结果分析CRE定植患者对常用抗菌药物的敏感性。另取同期在医院就诊的80例感染碳青霉烯类敏感肠杆菌目细菌(CSE)的患者设为对照组,比较定植组、对照组的临床资料,采用多因素Logistic回归分析筛选CRE定植的危险因素。
    结果 129例CRE定植患者共分离129株CRE, 以肺炎克雷伯菌、大肠埃希菌最为常见,占比分别为47.29%、18.60%;129株CRE主要分布于重症医学科、泌尿外科、胸外科,分别占比22.48%、16.28%、15.50%;129株常见CRE对哌拉西林/他唑巴坦、美罗培南等抗菌药物的耐药率较高,对替加环素、多黏菌素敏感性较高。定植组使用抗菌药物时间>2周、气管插管、留置导管、使用激素患者占比以及免疫抑制剂使用率高于对照组,差异有统计学意义(P < 0.05);2组性别、年龄、高血压、抗真菌药物使用情况、长期卧床、血红蛋白、体质量指数比较,差异无统计学意义(P>0.05)。多因素Logistic回归分析结果显示,使用抗菌药物时间>2周(95%CI: 1.289~5.407)、气管插管(95%CI: 1.065~5.006)、留置导管(95%CI: 1.020~5.129)、使用激素类药物(95%CI: 1.387~5.789)、使用免疫抑制剂(95%CI: 1.249~5.492)是CRE定植的危险因素(OR>1, P < 0.05)。
    结论 临床定植的CRE以肺炎克雷伯菌、大肠埃希菌最为常见,主要分布于重症医学科、泌尿外科、胸外科; CRE定植与使用抗菌药物时间>2周、气管插管、留置导管、使用激素类药物、使用免疫抑制剂等因素有关,临床应加强对易感患者的防护。

     

    Abstract:
    Objective To analyze the colonization status and clinical infection characteristics of carbapenem-resistant Enterobacterales (CRE) and to identify its risk factors.
    Methods From January 2021 to January 2023, 129 patients with CRE colonization admitted to our hospital were included in the colonization group, and the species identification results and departmental distribution of CRE were recorded. The sensitivity of CRE-colonized patients to commonly used antimicrobials was analyzed based on the results of antimicrobial susceptibility testing. Additionally, 80 patients with carbapenem-sensitive Enterobacterales (CSE) infections during the same period were recruited as control group. Clinical data between the colonization group and the control group were compared, and multivariate Logistic regression analysis was conducted to screen for risk factors for CRE colonization.
    Results A total of 129 CRE strains were isolated from 129 patients with CRE colonization, with Klebsiella pneumoniae and Escherichia coli being the most commonly seen bacteria, accounting for 47.29% and 18.60%, respectively. The 129 CRE strains were mainly distributed in the Critical Care Medicine Department, Urological Surgery Department, and Thoracic Surgery Department, with proportions of 22.48%, 16.28%, and 15.50%, respectively. The 129 common CRE strains exhibited high resistance rates to antimicrobials such as piperacillin/tazobactam and meropenem, and high sensitivity to tigecycline and polymyxin. The colonization group had a higher proportion of patients with antimicrobial use for >2 weeks, tracheal intubation, indwelling catheters, corticosteroid use, and immunosuppressant use compared to the control group (P < 0.05). There were no statistically significant differences in gender, age, hypertension, antifungal drug use, long-term bed rest, hemoglobin, or body mass index between the two groups (P>0.05). The results of multivariate Logistic regression analysis revealed that antimicrobial use for >2 weeks (95%CI, 1.289 to 5.407), tracheal intubation (95%CI, 1.065 to 5.006), indwelling catheters (95%CI, 1.020 to 5.129), corticosteroid use (95%CI, 1.387 to 5.789), and immunosuppressant use (95%CI, 1.249 to 5.492) were risk factors for CRE colonization (OR>1, P < 0.05).
    Conclusion Klebsiella pneumoniae and Escherichia coli are the most common species of CRE colonized clinically, primarily distributed in the Critical Care Medicine Department, Urological Surgery Department, and Thoracic Surgery Department. CRE colonization is associated with factors such as antimicrobial use for >2 weeks, tracheal intubation, indwelling catheters, corticosteroid use, and immunosuppressant use. Thus, enhanced protective measures for susceptible patients should be implemented clinically.

     

/

返回文章
返回